BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will speak at the 25th Annual JPMorgan Healthcare Conference on Thursday, January 11, 2007, at 12:30 p.m. Pacific Time. The conference is being held at the Westin St. Francis Hotel in San Francisco, California. Dr. Siegall’s presentation will provide an update on the company’s programs, including the recently announced exclusive global licensing agreement with Genentech for the development and commercialization of SGN-40.
